Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury.
about
The immunological effects of continuous veno-venous haemodiafiltration in critically ill patientsMechanisms of the systemic inflammatory response.CD62L (L-selectin) shedding for assessment of perioperative immune sensitivity in patients undergoing cardiac surgery with cardiopulmonary bypass.Pathogenesis of malaria and clinically similar conditions.Comparison of the myocardial protective effect of sevoflurane versus propofol in patients undergoing heart valve replacement surgery with cardiopulmonary bypassEffect of ulinastatin on perioperative organ function and systemic inflammatory reaction during cardiac surgery: a randomized double-blinded studyComparative effects of angiotensin receptor blockade and ACE inhibition on the fibrinolytic and inflammatory responses to cardiopulmonary bypassEffect of lornoxicam in lung inflammatory response syndrome after operations for cardiac surgery with cardiopulmonary bypass.An anti-inflammatory role for tranexamic acid in cardiac surgery?Modified ultrafiltration during cardiopulmonary bypass and postoperative course of pediatric cardiac surgery.The influence of biomaterials on inflammatory responses to cardiopulmonary bypass.A Thrombomodulin Gene Polymorphism (C1418T) Is Associated with Early Outcomes in Patients Undergoing Coronary Artery Bypass Graft Surgery with a Conventional Cardiopulmonary Bypass during Hospitalization.Macrophage migration inhibitory factor in pediatric patients undergoing surgery for congenital heart repair.The intraoperative effect of pentoxifylline on the inflammatory process and leukocytes in cardiac surgery patients undergoing cardiopulmonary bypass.The anti-inflammatory effect of bradykinin preconditioning in coronary artery bypass grafting (bradykinin and preconditioning).Predictive value of interleukin 6 (IL-6), interleukin 8 (IL-8) and gastric intramucosal pH (pH-i) in major abdominal surgery.Cytokine and S100B levels in paediatric patients undergoing corrective cardiac surgery with or without total circulatory arrest.High-dose ulinastatin improves postoperative oxygenation in patients undergoing aortic valve surgery with cardiopulmonary bypass: A retrospective study.Interleukin-8 secretion following cardiopulmonary bypass in children as a marker of early postoperative morbidity.Equivalence of the acute cytokine surge and myocardial injury after coronary artery bypass grafting with and without a novel extracorporeal circulation system.Induction of acute-phase reactive substances during open-heart surgery and efficacy of ulinastatin. Inhibiting cytokines and postoperative organ injury.Perioperative serum levels of tumour-necrosis-factor alpha (TNF-alpha), IL-1 beta, IL-6, IL-10 and soluble IL-2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution.Ulinastatin reduces elevation of cytokines and soluble adhesion molecules during cardiac surgery.A kinetic model of bone marrow neutrophil production that characterizes late phenotypic maturation.Interleukin-8 and acute kidney injury following cardiopulmonary bypass: a prospective cohort study.Effect of hemodiafiltration and sepsis on chemotaxis of granulocytes and the release of IL-8 and IL-10Eotaxin-2 induces monocytic apoptosis in patients who have undergone coronary artery bypass surgery and in THP-1 cells regulated by thrombomodulin
P2860
Q24794535-1C9DBA20-E744-40DD-8EEC-B6D147314742Q33717275-50F22F9B-FCC3-44DF-9742-F4F7FAA1C29DQ34542277-D9FC39FC-3EFB-4E4B-BC2F-01190CD1E48AQ35838590-A5CDB581-E7BB-4E33-921A-14AB6C672201Q36297233-94BB8CDA-1D04-4FA8-B772-08DBCA0B4E33Q36805947-2F97D23A-F995-46E1-AFAC-2688717B7263Q37294384-31DC2790-A1E6-4A80-93C5-D2ADFDBE538CQ37663883-5B51E2E8-BF8C-465C-AC29-9FBC66B41F12Q38275261-968C4B3B-9595-4328-BBC1-B746883BEB9DQ38283624-A49D8D1A-F34E-48DA-98BD-FFEFA94AB26EQ41118917-0B27586C-7CB4-4531-8644-C2A62B0C945CQ41529587-EF2ED297-A73C-4598-ADA7-780A5F35D73AQ42821740-AAD8A489-9E11-4416-B0D7-196B12FCF556Q45307532-2C27959E-74DC-47E0-B63D-F7E54C24590AQ46495944-E7D73BA4-8CE4-41AF-854A-19A51964E045Q48020771-1C245F23-641C-453D-9339-4336E57B827EQ48131102-99450FD0-8D1F-4FB1-BF59-47CABC9C019DQ48247704-867A81AE-A801-4E23-BCCB-87EC40314E7EQ49161982-D0294FC3-0676-4C05-BB54-2B5AEDA2309BQ51231871-AAADFF4D-A52C-422A-BCDA-406D119FE8E3Q51383249-5383FF45-B7E9-4133-9E12-B9549A52B17AQ51434203-718B8356-4FC8-41A9-A3DE-3297582CF262Q51571960-05DA8FDF-09D3-4C82-9F3E-0B742BC184CEQ51926290-40992F72-A8A1-4111-B4CF-7BDEFDC8D65AQ55687034-A2F46282-A9A1-420D-9011-308D3924B0B0Q56839556-69812A86-5C42-4D91-AA18-96ACC660A6E7Q58734006-D47CAFAC-905F-4A52-B262-963CE0FC7BA6
P2860
Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Elevation of cytokines during ...... 8 and 6 in reperfusion injury.
@en
Elevation of cytokines during ...... 8 and 6 in reperfusion injury.
@nl
type
label
Elevation of cytokines during ...... 8 and 6 in reperfusion injury.
@en
Elevation of cytokines during ...... 8 and 6 in reperfusion injury.
@nl
prefLabel
Elevation of cytokines during ...... 8 and 6 in reperfusion injury.
@en
Elevation of cytokines during ...... 8 and 6 in reperfusion injury.
@nl
P2093
P356
P1476
Elevation of cytokines during ...... 8 and 6 in reperfusion injury.
@en
P2093
P2888
P304
P356
10.1007/BF03009470
P577
1993-11-01T00:00:00Z